Emergency County Hospital "Constantin Opris", Baia Mare, Department of Forensic Medicine, Street George Coșbuc 31, Baia Mare, Maramures, 430031, Romania.
"Iuliu Haţieganu" University of Medicine and Pharmacy, Department of Internal Medicine, Street Victor Babeș 8, Cluj-Napoca, Cluj, 400347, Romania.
Leg Med (Tokyo). 2023 Sep;64:102293. doi: 10.1016/j.legalmed.2023.102293. Epub 2023 Jun 25.
Acute Myocardial Infarction (AMI) refers to the death of heart tissue in the absence ofperfusion. It is one of the top causes of death globally, particularly in middle andhigher-age groups. However, for the pathologist, the post-mortem macroscopic andmicroscopic diagnosis of early AMI remains challenging. In the early acute stage ofAMI, no microscopic visible signs of tissue alterations like necrosis and neutrophilinfiltration can be seen. In such a scenario, immunohistochemistry (IHC) accounts forthe most suitable and safest alternative to study early diagnostic cases by selectivelydetecting changes in the cell population. This systematic review focuses on themultiple causes/changes that lead to the privation of blood flow as well as tissuechanges induced by the absence of perfusion.We performed a systematic review of the last 10-15 years' publications that focused ondetecting immunohistochemical changes that appear in the cell population in case ofacute myocardial infarction. We found around 160 articles on AMI, which we narroweddown to 50 with the use of specific filters such as: "Acute Myocardial Infarction," "Ischemia," "Hypoxia," "Forensic," "Immunohistochemistry, and "Autopsy." The presentreview comprehensively highlights the current knowledge of specific IHC markers usedas gold standards during post-mortem investigation of acute myocardial infarction. Thepresent review comprehensively highlights the current knowledge of specific IHCmarkers used as gold standards during post-mortem investigation of acute myocardialinfarction, and some new potential immunohistochemical markers that can be used inthe early detection of myocardial infarction.
急性心肌梗死(AMI)是指在没有灌注的情况下心肌组织死亡。它是全球死亡的主要原因之一,特别是在中老年人中。然而,对于病理学家来说,早期 AMI 的死后大体和显微镜下诊断仍然具有挑战性。在 AMI 的早期急性阶段,没有可见的组织改变的微观迹象,如坏死和中性粒细胞浸润。在这种情况下,免疫组织化学(IHC)是研究早期诊断病例的最合适和最安全的替代方法,可以选择性地检测细胞群体的变化。本系统综述重点介绍了导致血流剥夺以及灌注缺失引起的组织变化的多种原因/变化。我们对过去 10-15 年的出版物进行了系统综述,这些出版物集中研究了在急性心肌梗死情况下细胞群体中出现的免疫组织化学变化。我们在 AMI 上找到了大约 160 篇文章,然后使用特定的过滤器将其缩小到 50 篇,例如:“急性心肌梗死”、“缺血”、“缺氧”、“法医”、“免疫组织化学”和“尸检”。本综述全面强调了在急性心肌梗死死后调查中用作金标准的特定 IHC 标志物的当前知识。本综述全面强调了在急性心肌梗死死后调查中用作金标准的特定 IHC 标志物的当前知识,以及一些可用于早期检测心肌梗死的新的潜在免疫组织化学标志物。